Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 5, 2026
- SINTX Technologies, Inc. reported third-quarter revenue of approximately $2.2 million versus $208,000, net loss of approximately $1.6 million, down 55%, and completed the limited-use release of the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System.
- 10-Q report · filed Nov 5, 2026
- SINTX Technologies reported total revenue growth of 315% for the nine months ended September 30, 2026, while net loss was $7.1 million and operating cash use was $6.6 million; substantial doubt remains about its ability to continue as a going concern.
The audio replay and transcript follow the call.